BET inhibitor molibresib for the treatment of advanced solid tumors: Final results from an open-label phase I/II study

Category Primary study
JournalJournal of Clinical Oncology
Year 2020
This article has no abstract
Epistemonikos ID: 4517af840cf1958479782d263c2751385a85a2ba
First added on: Feb 12, 2025